CBDY — what changed in the latest 10-Q
A section-by-section comparison of CBDY's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-08-13 vs the prior 10-Q · 2026-05-15
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +9 | −7 | ~13 | 34 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 1 |
| Legal proceedings | Text added/removed | 0 | 0 | ~2 | 1 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Not shown (absent or not faithfully extractable): Risk factors, Other information
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-08-13
The principal amount outstanding as of June 30, 2026 and December 31, 2025 was $480. At both reporting dates, the entire balance was current.
Statement of Operations – For the three months ended June 30, 2026 and 2025:
The Company generated revenue of $1,380,838 during the quarter ended in 2026 while $1,245,724 in the comparable period of 2025. The Company revenue represents the sale of cannabis product and the revenue was concentrated to three customers that represent over 10% of total revenue during the three mo…
The Company’s expenses are classified primarily into advisory and consultancy fees, management fees, salaries and wages, legal and professional fees, depreciation expense and office and general expense. The increase in operating expenses during the current quarter ended compared to comparable prior …
Statement of Operations – For the six months ended June 30, 2026 and 2025:
Text removed vs the prior filing · source: 10-Q · 2026-05-15
Interest amounting to $9 was accrued for the three months ended March 31, 2026 (March 31, 2025: $10).
The principal amount outstanding as of March 31, 2026 and December 31, 2025 was $480. At both reporting dates, the entire balance was current.
Statement of Operations – For the three months ended March 31, 2026 and 2025:
The Company generated revenue of $879,442 during the quarter ended in 2026 while $1,400,439 in the comparable period of 2025. The Company revenue represents the sale of cannabis product and the revenue was concentrated to three customers that represent over 10% of total revenue.
The Company’s expenses are classified primarily into advisory and consultancy fees, management fees, salaries and wages, legal and professional fees, depreciation expense and office and general expense. The decrease in operating expenses during the current quarter ended compared to comparable prior …
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice